RecruitingNot ApplicableNCT07202273

Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

A Feasibility Study of Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases (SIM-FREE RT)

Sponsor

University of Utah

Enrollment

40 participants

Start Date

Nov 3, 2025

Study Type

INTERVENTIONAL

Conditions

Bone Metastases

Summary

The goal of this study is to provide proof that patients can be treated with simulation-free, single-fraction palliative radiation therapy with a single in-person visit.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying simulation-free, single-fraction palliative radiation therapy for people with bone metastases. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONsimulation-free, single-fraction palliative radiation therapy

Radiation will be delivered in a single fraction. The recommended prescription dose is 8 Gy with external beam radiation therapy. Up to two sites of bone metastases may be treated on trial (i.e. no more than two radiation portals). Each site may have multiple lesions.